Lv32
326 积分 2021-03-02 加入
基于生物信息学分析斑秃的免疫浸润机制及中药治疗靶点预测
6小时前
已完结
BMP signaling drives follicle stem cell quiescence in alopecia areata
1天前
已关闭
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
4天前
已完结
2022年中国恶性肿瘤流行情况分析
1个月前
已完结
TACE联合多纳非尼及PD-1抑制剂治疗不可切除肝细胞癌的安全性和有效性分析
1个月前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
2个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
2个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
3个月前
已完结
EGFR activation limits the response ofliver cancer to lenvatinib
3个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
4个月前
已完结
皖公网安备34019202002308
